Newswise — Scientific breakthroughs in molecular targeting, translational cancer research and cancer prevention will take center stage when more than 17,000 scientists from around the world gather at the Walter E. Washington Convention Center, April 17-21, for the AACR 101st Annual Meeting 2010.
“We are now entering our second century of Annual Meetings and I believe we will have the ability to control this disease in the near term,” said Tyler Jacks, Ph.D., president of the American Association for Cancer Research and director of the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology.
“This does not mean that we will cure all diseases, but cancer patients will experience significantly longer survival, including those with the most devastating diagnosis, as we implement the new approaches we’re discovering today,” he said.
The theme of the AACR 101st Annual Meeting 2010 is “Conquering Cancer Through Discovery Research,” and scientists from many disciplines will present approximately 6,300 abstracts in all aspects of cancer. This year’s Annual Meeting will feature an expanded number of plenary sessions where new, exciting information will be presented on familiar topics like cancer genetics, but also new arenas like small RNAs, nanotechnology and systems biology, according to Jacks.
To help guide coverage of the conference, the AACR Communications Department has planned the following six press conferences:
• BATTLE Trial Confirms Efficacy of Personalized Medicine in Lung Cancer• Emerging Technologies: Diagnosis and Treatment • MicroRNAs May be Key to Cancer Knowledge and Future Cures• Breast Cancer Prevention: Raloxifene as Effective as Tamoxifen with Fewer Side Effects • How Infection and Inflammation Can Lead to Cancer• Cancer Prevention Strategies Highlighted at AACR 101st Annual Meeting 2010
In addition, the American Association for Cancer Research has issued the following releases on studies that may be of interest to the media:• Mammographic Density and Risk of Breast Cancer: New Findings Presented at the AACR 101st Annual Meeting 2010• Cancer Health Disparities Research Highlighted at AACR 101st Annual Meeting 2010• Excessive Alcohol Consumption May Lead to Increased Cancer Risk• Metformin May Prevent Lung Cancer in Smokers• Advocates and Researchers Educate Community About Cancer in Game Show Format• First-In-Class Drug BBI608 Tested in Patients with Advanced Cancer • Increased EGFR Levels May be an Early Marker of Breast Cancer• Vitamin and Calcium Supplements May Reduce Breast Cancer Risk• Body Mass Index Gain Throughout Adulthood May Increase Risk of Postmenopausal Breast Cancer• Biomarkers Help Predict Prostate Cancer Progression • Statins Do Not Protect Patients Against Risk of Colorectal Adenoma• Cancer Health Disparities Research Highlighted at AACR 101st Annual Meeting 2010
Download interviews with cancer researchers and recordings of the teleconferences by subscribing to the AACR Scientific Podcasts via iTunes (http://www.aacr.org/itunes) or an RSS Reader (http://www.aacr.org/rss).
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 31,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.
RSS